More Than 75 Emerging Biotechs Use Veeva Basics Across Clinical, Regulatory, and Quality

Delivers pre-configured, pre-validated software that can scale with the needs of fast-growing companiesPLEASANTON, Calif., May 20, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Veeva Basics is being used by more than 75 biotechs to gain efficiency and reduce costs across clinical, regulatory, and quality. With standardized applications, biotechs are going live with industry-leading software in weeks and gaining a system that can scale as they expand their business. The rapid adoption ...